MedCity News July 1, 2021
Khadijah M. Silver

Despite mounting court and legislative scrutiny of pharmacy and prescription benefit manager practices, Amazon has chosen to throw its hat into the discount pharmacy ring. Could Amazon “disrupt” prescription drug delivery?

CVS Health recently won a reprieve from a federal jury clearing the pharmacy from claims that it systematically overcharged insured customers buying prescription drugs from its retail pharmacies by $121 million. However, the industry remains mired in litigation, with Walgreens, Kroger, Rite Aid and others facing similar charges.

Legislators, regulators and government watchdogs have also recently taken aim at not only pharmacies but also pharmacy benefit managers (PBMs) that negotiate discounts between drug suppliers and sellers, arguing that their opaque practices drive up pharmaceutical costs.

“This is a market...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider, Retailer
Aviv Regev: The Revolution in Digital Biology
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)

Share This Article